Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection by Fernandez, E, Dejnirattisai, W, Cao, B, Scheaffer, SM, Supasa, P, Wongwiwat, W, Esakky, P, Drury, A, Mongkolsapaya, J, Moley, KH, Mysorekar, IU, Screaton, GR, Diamond, MS

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum by Dejnirattisai, W, Shaw, RH, Supasa, P, Liu, C, Stuart, AS, Pollard, AJ, Liu, X, Lambe, T, Crook, D, Stuart, DI, Mongkolsapaya, J, Nguyen-Van-Tam, JS, Snape, MD, Screaton, GR

Cooperativity and induced oligomerization control the interaction of SARS-CoV-2 with its cellular receptor and patient-derived antibodies by Asor, R, Olerinyova, A, Burnap, SA, Kushwah, MS, Hensen, M, Vasiljevic, S, Chang, L, Dejnirattisa, W, Supasa, P, Stuart, DI, Screaton, GR, Zitzmann, N, Benesch, JLP, Struwe, WB, Kukura, P

Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus by Renner, M, Flanagan, A, Dejnirattisai, W, Puttikhunt, C, Kasinrerk, W, Supasa, P, Wongwiwat, W, Chawansuntati, K, Duangchinda, T, Cowper, A, Midgley, C, Malasit, P, Huiskonen, J, Mongkolsapaya, J, Screaton, G, Grimes, J

Longitudinal analysis of antibody cross-neutralization following Zika and dengue virus infection in Asia and the Americas by Montoya, M, Collins, M, Dejnirattisai, W, Katzelnick, LC, Puerta-Guardo, H, Jadi, R, Schildhauer, S, Supasa, P, Vasanawathana, S, Malasit, P, Mongkolsapaya, J, de Silva, AD, Tissera, H, Balmaseda, A, Screaton, GR, de Silva, AM, Harris, E

Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition by Asor, R, Olerinyova, A, Burnap, SA, Kushwah, M, Soltermann, F, Rudden, LSP, Hensen, M, Vasiljevic, S, Brun, J, Hill, M, Chang, L, Dejnirattisa, W, Supasa, P, Mogkolsapaya, J, Zhou, D, Stuart, D, Screaton, GR, Degiacomi, M, Zitzmann, N, Benesch, J, Struwe, W, Kukura, P

Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine by Watanabe, Y, Mendonça, L, Allen, ER, Howe, A, Lee, M, Allen, JD, Chawla, H, Pulido, D, Donnellan, F, Davies, H, Ulaszewska, M, Belij-Rammerstorfer, S, Morris, S, Krebs, A-S, Dejnirattisai, W, Mongkolsapaya, J, Supasa, P, Screaton, GR, Green, CM, Lambe, T, Zhang, P, Gilbert, SC, Crispin, M

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody lev... by Harvala, H, Robb, ML, Watkins, N, Ijaz, S, Dicks, S, Patel, M, Supasa, P, Wanwisa, D, Liu, C, Mongkolsapaya, J, Bown, A, Bailey, D, Vipond, R, Grayson, N, Temperton, N, Gupta, S, Ploeg, RJ, Bolton, J, Fyfe, A, Gopal, R, Simmonds, P, Screaton, G, Thompson, C, Brooks, T, Zambon, M, Miflin, G, Roberts, DJ

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy by Ragonnet-Cronin, M, Nutalai, R, Huo, J, Dijokaite-Guraliuc, A, Das, R, Tuekprakhon, A, Supasa, P, Liu, C, Selvaraj, M, Groves, N, Hartman, H, Ellaby, N, Mark Sutton, J, Bahar, MW, Zhou, D, Fry, E, Ren, J, Brown, C, Klenerman, P, Dunachie, SJ, Mongkolsapaya, J, Hopkins, S, Chand, M, Stuart, DI, Screaton, GR, Rokadiya, S

Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination. by Yin, Z, Chen, J-L, Lu, Y, Wang, B, Godfrey, L, Mentzer, AJ, Yao, X, Liu, G, Wellington, D, Zhao, Y, Wing, PAC, Dejnirattisa, W, Supasa, P, Liu, C, Hublitz, P, Beveridge, R, Waugh, C, Clark, S-A, Clark, K, Sopp, P, Rostron, T, Mongkolsapaya, J, Screaton, GR, Ogg, G, Ewer, K, Pollard, AJ, Gilbert, S, Knight, JC, Lambe, T, Smith, GL, Dong, T, Peng, Y

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, singl... by Costa Clemens, SA, Weckx, L, Clemens, R, Almeida Mendes, AV, Ramos Souza, A, Silveira, MBV, da Guarda, SNF, de Nobrega, MM, de Moraes Pinto, MI, Gonzalez, IGS, Salvador, N, Franco, MM, de Avila Mendonça, RN, Queiroz Oliveira, IS, de Freitas Souza, BS, Fraga, M, Aley, P, Bibi, S, Cantrell, L, Dejnirattisai, W, Liu, X, Mongkolsapaya, J, Supasa, P, Screaton, GR, Lambe, T, Voysey, M, Pollard, AJ

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants by Liu, C, Zhou, D, Nutalai, R, Duyvesteyn, HME, Tuekprakhon, A, Ginn, HM, Dejnirattisai, W, Supasa, P, Mentzer, AJ, Wang, B, Case, JB, Zhao, Y, Skelly, DT, Chen, RE, Johnson, SA, Ritter, TG, Mason, C, Malik, T, Temperton, N, Paterson, NG, Williams, MA, Hall, DR, Clare, DK, Howe, A, Goulder, PJR, Fry, EE, Diamond, MS, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees by Nutalai, R, Zhou, D, Tuekprakhon, A, Ginn, HM, Supasa, P, Liu, C, Huo, J, Mentzer, AJ, Duyvesteyn, HME, Dijokaite-Guraliuc, A, Skelly, D, Ritter, TG, Amini, A, Bibi, S, Adele, S, Johnson, SA, Constantinides, B, Webster, H, Temperton, N, Klenerman, P, Barnes, E, Dunachie, SJ, Crook, D, Pollard, AJ, Lambe, T, Goulder, P, Paterson, NG, Williams, MA, Hall, DR, Mongkolsapaya, J, Fry, EE, Dejnirattisai, W, Ren, J, Stuart, DI, Screaton, GR

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum by Tuekprakhon, A, Nutalai, R, Dijokaite-Guraliuc, A, Zhou, D, Ginn, HM, Selvaraj, M, Liu, C, Mentzer, AJ, Supasa, P, Duyvesteyn, HME, Das, R, Skelly, D, Ritter, TG, Amini, A, Bibi, S, Adele, S, Johnson, SA, Constantinides, B, Webster, H, Temperton, N, Klenerman, P, Barnes, E, Dunachie, SJ, Crook, D, Pollard, AJ, Lambe, T, Goulder, P, Paterson, NG, Williams, MA, Hall, DR, ISARIC4C Consortium, Fry, EE, Huo, J, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75 by Huo, J, Dijokaite-Guraliuc, A, Liu, C, Zhou, D, Ginn, HM, Das, R, Supasa, P, Selvaraj, M, Nutalai, R, Tuekprakhon, A, Duyvesteyn, HME, Mentzer, AJ, Skelly, D, Ritter, TG, Amini, A, Bibi, S, Adele, S, Johnson, SA, Paterson, NG, Williams, MA, Hall, DR, Plowright, M, Newman, TAH, Hornsby, H, de Silva, TI, Temperton, N, Klenerman, P, Barnes, E, Dunachie, SJ, Pollard, AJ, Lambe, T, Goulder, P, OPTIC consortium, ISARIC4C consortium, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 by Thompson, CP, Grayson, N, Paton, R, Bolton, JS, Lourenco, J, Penman, B, Lee, LN, Odon, V, Mongkolsapaya, J, Chinnakannan, S, Dejnirattisai, W, Edmans, M, Fyfe, A, Imlach, C, Kooblall, K, Lim, N, Liu, C, Lopez-Camacho, C, McInally, C-A, McNaughton, AL, Ramamurthy, N, Ratcliff, J, Supasa, P, Wang, B, Mentzer, AJ, Turner, M, Sampson, O, Semple, C, Baillie, JK, ISARIC4C Investigators, Harvala, H, Screaton, G, Temperton, N, Klenerman, P, Jarvis, L, Gupta, S, Simmonds, P

Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history by Hornsby, H, Nicols, AR, Longet, S, Liu, C, Tomic, A, Angyal, A, Kronsteiner, B, Tyerman, JK, Tipton, T, Zhang, P, Gallis, M, Supasa, P, Selvaraj, M, Abraham, P, Neale, I, Ali, M, Barratt, NA, Nell, JM, Gustafsson, L, Strickland, S, Grouneva, I, Rostron, T, Moore, SC, Hering, LM, Dobson, SL, Bibi, S, Mongkolsapaya, J, Lambe, T, Wootton, D, Hall, V, Hopkins, S, Dong, T, Barnes, E, Screaton, G, Richter, A, Turtle, L, Rowland-Jones, SL, Carroll, M, Duncan, CJA, Klenerman, P, Dunachie, SJ, Payne, RP, de Silva, TI

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera by Zhou, D, Dejnirattisai, W, Supasa, P, Liu, C, Mentzer, AJ, Ginn, HM, Zhao, Y, Duyvesteyn, HME, Tuekprakhon, A, Nutalai, R, Wang, B, Paesen, GC, Lopez-Camacho, C, Slon-Campos, J, Hallis, B, Coombes, N, Bewley, K, Charlton, S, Walter, TS, Skelly, D, Lumley, SF, Dold, C, Levin, R, Pollard, AJ, Dong, T, Knight, JC, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, S, James, W, Carroll, MW, Klenerman, P, Barnes, E, Dunachie, SJ, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient by Zhou, D, Duyvesteyn, HME, Chen, C-P, Huang, C-G, Chen, T-H, Shih, S-R, Lin, Y-C, Cheng, C-Y, Cheng, S-H, Huang, Y-C, Lin, T-Y, Ma, C, Huo, J, Carrique, L, Malinauskas, T, Ruza, RR, Shah, PNM, Tan, TK, Rijal, P, Donat, RF, Godwin, K, Buttigieg, KR, Tree, JA, Radecke, J, Paterson, NG, Supasa, P, Mongkolsapaya, J, Screaton, GR, Carroll, MW, Gilbert-Jaramillo, J, Knight, ML, James, W, Owens, RJ, Naismith, JH, Townsend, AR, Fry, EE, Zhao, Y, Ren, J, Stuart, DI, Huang, K-YA

Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens by Moore, SC, Kronsteiner, B, Longet, S, Adele, S, Deeks, AS, Liu, C, Dejnirattisai, W, Reyes, LS, Meardon, N, Faustini, S, Al-Taei, S, Tipton, T, Hering, LM, Angyal, A, Brown, R, Nicols, AR, Dobson, SL, Supasa, P, Tuekprakhon, A, Cross, A, Tyerman, JK, Hornsby, H, Grouneva, I, Plowright, M, Zhang, P, Newman, TAH, Nell, JM, Abraham, P, Ali, M, Malone, T, Neale, I, Phillips, E, Wilson, JD, Murray, SM, Zewdie, M, Shields, A, Horner, EC, Booth, LH, Stafford, L, Bibi, S, Wootton, DG, Mentzer, AJ, Conlon, CP, Jeffery, K, Matthews, PC, Pollard, AJ, Brown, A, Rowland-Jones, SL, Mongkolsapaya, J, Payne, RP, Lambe, T, Screaton, G, Carroll, M, Klenerman, P, Dunachie, S